INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 06,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 1114
HEALTH STATUS OF NEWBORNS: FEATURES OF BRONCHO-OBSTRUCTIVE
SYNDROME IN INFANTS BORN VIA IVF METHOD
Sharipov Rustam Khaitovich
Head of the Department of Pediatrics and Neonatology,
Doctor of Medical Sciences, Associate Professor, Faculty of Advanced Education,
Samarkand State Medical University
Abstract:
This article highlights the clinical course of broncho-obstructive syndrome in
newborns, particularly in those born via in vitro fertilization (IVF). Infants born through IVF
often show underdeveloped respiratory systems, bronchial hyperreactivity, and a predisposition
to pulmonary insufficiency syndromes. The article discusses the pathogenesis, clinical signs,
and modern treatment approaches for broncho-obstructive syndrome.
Keywords:
infant health, in vitro fertilization, broncho-obstructive syndrome, respiratory
failure, neonatology, perinatal risk
Introducion
The health of newborns is one of the most pressing topics in the field of neonatology
today. Particularly, newborns born via in vitro fertilization (IVF) are found to be at a higher risk
for various respiratory disorders during the perinatal and postnatal periods, including broncho-
obstructive syndromes. Babies born through IVF often develop under complicated or prolonged
pregnancies. In such cases, maternal hormonal, immunological, or pharmacological factors may
contribute to difficulties in the development of the infant's primary airways.
Broncho-obstructive syndrome manifests in the neonatal period with signs such as
shortness of breath, wheezing, expiratory dyspnea, and chest retraction. This condition results
from swelling of the bronchial walls, mucus accumulation, and muscle spasms. In IVF-born
infants, these processes are often related to morphologic and functional immaturity of the lung
tissue. These children tend to exhibit bronchial hyperreactivity, showing heightened responses
even to minor infections or allergens.
In modern neonatology, early diagnosis and personalized treatment approaches for this
syndrome are of significant importance. Contemporary diagnostic methods such as respiratory
rate monitoring, pulse oximetry, chest radiography, and laboratory evaluations are used to
assess the severity of broncho-obstructive conditions in neonates.
Treatment options include pulmonary ventilation, bronchodilators, glucocorticosteroids,
and oxygen therapy. In IVF-born infants, this therapy must be administered cautiously and
gradually, given their lower lung elasticity and more sensitive respiratory centers.
Additionally, it is recommended that infants born via IVF undergo long-term monitoring to
evaluate bronchial and immune system development during growth. Clinical practice shows
that such children are more susceptible to chronic bronchitis, asthma, or other respiratory
diseases in early childhood. Therefore, early and comprehensive interventions against broncho-
obstructive syndrome are essential, including rehabilitation and structured preventive care.
Newborns born via IVF are often at risk for various perinatal and neonatal
complications. These complications are directly associated with high-risk pregnancies,
premature birth, multiple gestations, or maternal chronic conditions. In this group of infants, the
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 06,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 1115
respiratory system may be underdeveloped, with immature alveoli and incomplete formation of
the bronchial tree.
The pathophysiology of broncho-obstructive syndrome involves bronchial narrowing, mucosal
hyperplasia, excessive mucus production, and smooth muscle spasms in the airways. This
restricts air entry into the alveoli, leading to hypoxia and carbon dioxide retention. Viral
infections, especially RSV (respiratory syncytial virus), often serve as primary triggers for this
syndrome. However, in IVF-born infants, immune responses to such infections tend to be
weaker.
Diagnosis involves identifying rapid breathing, chest retraction, whistling wheeze
during exhalation, and in severe cases, cyanosis and respiratory failure. On auscultation, moist
rales and reduced breath sounds may be heard. Diagnostic confirmation includes chest X-ray,
pulse oximetry, arterial blood gas analysis, and differential diagnostics.
Treatment strategies depend on the severity of the syndrome. In mild cases, symptomatic
management is sufficient: warm steam inhalations, nasal passage clearance, and positioning to
ease breathing. In moderate to severe cases, bronchodilators (such as salbutamol, ipratropium
bromide), inhaled glucocorticosteroids, supplemental oxygen, or even mechanical ventilation
may be necessary. In cases of weakened immunity, immunomodulatory therapy (e.g.,
interferons, vitamin support) is also recommended.
In conclusion, infants born through IVF possess specific physiological characteristics
that require specialized assessment and management strategies. Recent scientific literature
confirms that pregnancies resulting in IVF births are often classified as high-risk. These infants
are commonly premature and have immature respiratory systems, increasing their likelihood of
developing broncho-obstructive syndromes. Additionally, postnatal interventions such as
resuscitation, mechanical ventilation, and antibiotic therapy may disrupt respiratory microbiota.
Broncho-obstructive syndrome tends to follow a more chronic course in IVF-born infants.
Clinical observations show frequent cases of delayed respiratory insufficiency, recurrent
respiratory infections, and prolonged wheezing episodes in such infants. Treatment should be
comprehensive, addressing the underlying causes and incorporating symptom relief and
immune support. Antiviral and antifungal agents, bronchodilators, respiratory physiotherapy,
and breathing exercises are widely used.
Modern neonatology places special emphasis on using nebulized inhalation therapy,
positional treatment, percussion massage, and airway drainage for managing broncho-
obstructive syndrome. Each clinical case in IVF-born infants must be approached individually.
Continuous monitoring by pediatricians, pulmonologists, and immunologists during the infant’s
first year of life is strongly advised.
Preventive measures are especially vital for infants born via IVF. Maintaining maternal health
during pregnancy, perinatal supervision, controlled labor conditions, coordinated neonatal care
after birth, and regular follow-up in the first year play key roles in preserving infant health and
preventing broncho-obstructive syndrome. Early detection, accurate evaluation, and modern
treatment are crucial to ensuring long-term health outcomes. For neonatologists and
pediatricians, continuous monitoring and individualized care for such infants is essential.
References:
1. Clinical protocols of the Ministry of Health of the Republic of Uzbekistan – Neonatology
guidelines
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 06,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 1116
2. World Health Organization (2023). Neonatal and Child Health Guidelines
3. Gromova E.A., Vorontsov I.M. (2021). “Broncho-Obstructive Syndrome: Clinical Course
and Modern Approaches,” Journal of Pediatrics
4. Reproductive Biology and Endocrinology (RB&E), 2022 – “Respiratory outcomes in IVF-
born infants”
5. Ospanova N.A. et al. (2020). “Perinatal Risk Factors in IVF-born Infants.” Materials from
Tashkent Medical Academy
